A majority of patients diagnosed with CLL respond well to first-line treatment. But, given the pathophysiology of CLL, recurrence is inevitable for many. Fortunately, treatment for relapsed/refractory CLL has significantly improved in recent years, with data showing prolonged progression-free survival in this population.
Do you know the basics about relapsed/refractory CLL? Test your knowledge with this quick quiz.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Karl J. D'Silva, Emmanuel C. Besa, Anand Patel. Fast Five Quiz: Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) - Medscape - Oct 11, 2023.